FGF22

fibroblast growth factor 22, the group of Fibroblast growth factor family

Basic information

Region (hg38): 19:639879-644373

Links

ENSG00000070388NCBI:27006OMIM:605831HGNC:3679Uniprot:Q9HCT0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FGF22 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FGF22 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
32
clinvar
3
clinvar
35
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 32 3 0

Variants in FGF22

This is a list of pathogenic ClinVar variants found in the FGF22 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-639929-C-T not specified Uncertain significance (Mar 03, 2025)3850125
19-639943-G-T not specified Uncertain significance (Jul 27, 2021)2375348
19-639959-C-G not specified Uncertain significance (Jan 03, 2022)2351813
19-639968-G-A not specified Uncertain significance (Sep 22, 2023)3094733
19-639978-C-T not specified Uncertain significance (Jun 24, 2022)2296770
19-639996-C-G not specified Uncertain significance (Jul 30, 2024)3514951
19-640025-C-T not specified Uncertain significance (Feb 27, 2024)3094724
19-640038-G-A not specified Uncertain significance (Sep 10, 2024)3514952
19-640055-C-A not specified Uncertain significance (May 18, 2023)2549214
19-640097-G-A not specified Likely benign (Mar 31, 2024)3278638
19-640097-G-C not specified Uncertain significance (May 30, 2023)2553030
19-640110-A-G not specified Uncertain significance (Aug 15, 2023)2601526
19-640134-A-G not specified Uncertain significance (Dec 02, 2024)3094725
19-643244-A-T not specified Uncertain significance (Feb 06, 2025)3850127
19-643258-C-T not specified Uncertain significance (Oct 21, 2024)3514954
19-643261-G-A not specified Uncertain significance (Jul 27, 2021)2378049
19-643265-G-T not specified Uncertain significance (Mar 08, 2025)3850123
19-643310-T-C not specified Uncertain significance (Apr 23, 2024)3278636
19-643312-A-T not specified Uncertain significance (Dec 17, 2023)3094727
19-643322-G-C not specified Uncertain significance (Oct 17, 2023)3094728
19-643324-C-T not specified Uncertain significance (Dec 25, 2024)3850124
19-643325-G-A not specified Uncertain significance (Dec 09, 2024)3514950
19-643334-G-C not specified Uncertain significance (Mar 29, 2022)2280840
19-643337-C-T not specified Uncertain significance (Feb 28, 2025)2396202
19-643422-G-A not specified Uncertain significance (Aug 30, 2022)2205895

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FGF22protein_codingprotein_codingENST00000215530 33825
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
6.67e-70.08291245721591246320.000241
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.79712299.61.220.000008101036
Missense in Polyphen5749.6641.1477444
Synonymous-0.1594341.71.030.00000313395
Loss of Function-1.0185.461.463.19e-761

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002200.00208
Ashkenazi Jewish0.000.00
East Asian0.00005560.0000546
Finnish0.000.00
European (Non-Finnish)0.00006440.0000624
Middle Eastern0.00005560.0000546
South Asian0.0004650.000425
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a role in the fasting response, glucose homeostasis, lipolysis and lipogenesis. Can stimulate cell proliferation (in vitro). May be involved in hair development. {ECO:0000269|PubMed:16597617}.;
Pathway
PI3K-Akt signaling pathway - Homo sapiens (human);Gastric cancer - Homo sapiens (human);Melanoma - Homo sapiens (human);Breast cancer - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Ras signaling pathway - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);MAPK Signaling Pathway;ESC Pluripotency Pathways;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;Regulation of Actin Cytoskeleton;FGFR2b ligand binding and activation;FGFR2 ligand binding and activation;FRS-mediated FGFR2 signaling;Negative regulation of FGFR2 signaling;Signaling by FGFR2;Phospholipase C-mediated cascade; FGFR2;SHC-mediated cascade:FGFR2;PI-3K cascade:FGFR2;Downstream signaling of activated FGFR2;Disease;Signal Transduction;Signaling by FGFR;PI3K Cascade;IRS-mediated signalling;Insulin receptor signalling cascade;Activated point mutants of FGFR2;Signaling by Insulin receptor;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;FGF;Signaling by FGFR2 in disease;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;PIP3 activates AKT signaling;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Negative regulation of the PI3K/AKT network;FGFR2 mutant receptor activation;Signaling by FGFR in disease;Constitutive Signaling by Aberrant PI3K in Cancer;PI3K/AKT Signaling in Cancer;GPCR signaling-G alpha i;IRS-related events triggered by IGF1R;IGF1R signaling cascade;Signaling by Receptor Tyrosine Kinases;Intracellular signaling by second messengers;Phospholipase C-mediated cascade: FGFR1;Diseases of signal transduction;FGFR1b ligand binding and activation;Downstream signaling of activated FGFR1;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R);FGFR1 ligand binding and activation;FGFRL1 modulation of FGFR1 signaling;FRS-mediated FGFR1 signaling;SHC-mediated cascade:FGFR1;PI-3K cascade:FGFR1;Negative regulation of FGFR1 signaling;Signaling by FGFR1 (Consensus)

Recessive Scores

pRec
0.126

Haploinsufficiency Scores

pHI
0.353
hipred
N
hipred_score
0.197
ghis
0.566

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.126

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Fgf22
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); neoplasm; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
fgf22
Affected structure
roof plate midbrain region
Phenotype tag
abnormal
Phenotype quality
increased width

Gene ontology

Biological process
MAPK cascade;fibroblast growth factor receptor signaling pathway;regulation of signaling receptor activity;peptidyl-tyrosine phosphorylation;cell differentiation;phosphatidylinositol-3-phosphate biosynthetic process;phosphatidylinositol phosphorylation;positive regulation of protein kinase B signaling
Cellular component
extracellular region;extracellular space;nucleolus;Golgi apparatus;cell surface
Molecular function
protein tyrosine kinase activity;Ras guanyl-nucleotide exchange factor activity;fibroblast growth factor receptor binding;growth factor activity;1-phosphatidylinositol-3-kinase activity;phosphatidylinositol-4,5-bisphosphate 3-kinase activity